SEC Form 4 · accession 0000914190-16-000832
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin S Gould
Officer — SVP Clinical Controls
Period of report
Sep 8, 2016
Accepted (ET)
Sep 12, 2016 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 8, 2016 | S | 524 | $110.503 | D | 1,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to Buy)F3 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to Buy)F4 | $88.23 | holding | — | — | — | — | Jan 4, 2023 | Common Stock | 10,000 | 10,000 | D |
| Stock Options (Right to Buy)F5 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 17,371 | 17,371 | D |
| Stock Options (Right to Buy)F6 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 13,028 | 13,028 | D |
| Restricted Stock UnitsF7,F6 | — | holding | — | — | — | — | — | Common Stock | 2,111 | 2,111 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.4934 to $110.5402 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- F350,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.
- F4Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.
- F5Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- F6Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F7Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.